chr9-124015305-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_004789.4(LHX2):c.507C>A(p.Phe169Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,613,912 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
LHX2
NM_004789.4 missense
NM_004789.4 missense
Scores
4
10
5
Clinical Significance
Conservation
PhyloP100: 1.21
Genes affected
LHX2 (HGNC:6594): (LIM homeobox 2) This gene encodes a protein belonging to a large protein family, members of which carry the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein may function as a transcriptional regulator. The protein can recapitulate or rescue phenotypes in Drosophila caused by a related protein, suggesting conservation of function during evolution. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHX2 | NM_004789.4 | c.507C>A | p.Phe169Leu | missense_variant | 3/5 | ENST00000373615.9 | NP_004780.3 | |
LHX2 | XM_006717323.4 | c.507C>A | p.Phe169Leu | missense_variant | 3/6 | XP_006717386.1 | ||
LHX2 | XM_047424082.1 | c.507C>A | p.Phe169Leu | missense_variant | 3/6 | XP_047280038.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHX2 | ENST00000373615.9 | c.507C>A | p.Phe169Leu | missense_variant | 3/5 | 1 | NM_004789.4 | ENSP00000362717 | P1 | |
LHX2 | ENST00000446480.5 | c.525C>A | p.Phe175Leu | missense_variant | 3/5 | 2 | ENSP00000394978 | |||
LHX2 | ENST00000560961.2 | c.384C>A | p.Phe128Leu | missense_variant | 3/3 | 3 | ENSP00000453448 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152264Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152264
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 251002Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135812
GnomAD3 exomes
AF:
AC:
2
AN:
251002
Hom.:
AF XY:
AC XY:
2
AN XY:
135812
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461648Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727116
GnomAD4 exome
AF:
AC:
3
AN:
1461648
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
727116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74388
GnomAD4 genome
AF:
AC:
10
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.507C>A (p.F169L) alteration is located in exon 3 (coding exon 3) of the LHX2 gene. This alteration results from a C to A substitution at nucleotide position 507, causing the phenylalanine (F) at amino acid position 169 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
0.045
.;B
Vest4
0.88
MutPred
0.69
.;Loss of catalytic residue at F169 (P = 0.0224);
MVP
MPC
1.3
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at